Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa

<p>Abstract</p> <p>Background</p> <p>Lamivudine <b>(</b>3TC) is a potent inhibitor of both Hepatitis B virus (HBV) and Human Immunodeficiency Virus (HIV) replication and is part of first-line highly active antiretroviral therapy (HAART) in the Gambia. Unfortunately, the effectiveness of 3TC against...

Descrición completa

Detalles Bibliográficos

Principais autores:	Stewart Balint, Jobarteh Modou L, Sarge-Njie Ramu, Alabi Abraham, de Silva Thushan, Peterson Kevin, Peterson Ingrid, Whittle Hilton, Rowland-Jones Sarah, Jaye Assan, Cotten Matthew, Mendy Maimuna
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2011-12-01
Series:	BMC Research Notes
Acceso en liña:	http://www.biomedcentral.com/1756-0500/4/561
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!